Certara Stock Today
| CERT Stock | USD 6.62 0.05 0.75% |
PerformanceWeakest
| Odds Of DistressAverage
|
Certara is selling for under 6.62 as of the 16th of February 2026; that is 0.75 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 6.62. Certara has 52 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. The performance scores are derived for the period starting the 18th of November 2025 and ending today, the 16th of February 2026. Click here to learn more.
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey. The company has 159.27 M outstanding shares of which 20.81 M shares are currently shorted by private and institutional investors with about 10.99 trading days to cover. More on Certara
Moving together with Certara Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Certara Stock Highlights
Certara (CERT) is traded on NASDAQ Exchange in USA and employs 1,487 people. Certara is listed under Health Care Technology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.05 B. Certara conducts business under Health Care Technology sector and is part of Health Care industry. The entity has 159.27 M outstanding shares of which 20.81 M shares are currently shorted by private and institutional investors with about 10.99 trading days to cover.
Certara currently holds about 195.44 M in cash with 80.47 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.22.
Check Certara Probability Of Bankruptcy
Ownership AllocationThe majority of Certara outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Certara to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Certara. Please pay attention to any change in the institutional holdings of Certara as this could imply that something significant has changed or is about to change at the company.
Check Certara Ownership Details
Certara Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Certara market risk premium is the additional return an investor will receive from holding Certara long position in a well-diversified portfolio.
| Mean Deviation | 2.12 | |||
| Standard Deviation | 2.8 | |||
| Variance | 7.84 | |||
| Risk Adjusted Performance | (0.08) |
Certara Stock Against Markets
Certara Corporate Management
| Richard Traynor | General VP | Profile | |
| PharmD Bois | Head Advisor | Profile | |
| Frederic Bois | Head Advisor | Profile | |
| Hannah Jones | Senior Services | Profile | |
| Sheila MBA | Chief Officer | Profile | |
| Ron DiSantis | Senior Development | Profile |
Additional Tools for Certara Stock Analysis
When running Certara's price analysis, check to measure Certara's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Certara is operating at the current time. Most of Certara's value examination focuses on studying past and present price action to predict the probability of Certara's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Certara's price. Additionally, you may evaluate how the addition of Certara to your portfolios can decrease your overall portfolio volatility.